Your browser doesn't support javascript.
loading
Sustained release and improved bioavailability in mice after subcutaneous administration of griseofulvin as nano- and microcrystals.
Sigfridsson, Kalle; Xue, Aixiang; Goodwin, Kelly; Fretland, Adrian J; Arvidsson, Torbjörn.
Afiliación
  • Sigfridsson K; Advanced Drug Delivery, Pharmaceutical Science, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. Electronic address: carl-gustav.sigfridsson@astrazeneca.com.
  • Xue A; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Boston, USA.
  • Goodwin K; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Boston, USA.
  • Fretland AJ; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Boston, USA.
  • Arvidsson T; Early Product Development, Pharmaceutical Science, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
Int J Pharm ; 566: 565-572, 2019 Jul 20.
Article en En | MEDLINE | ID: mdl-31181305
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nanopartículas / Griseofulvina / Antifúngicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Pharm Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nanopartículas / Griseofulvina / Antifúngicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Pharm Año: 2019 Tipo del documento: Article